Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Comparison of Susceptibility-Weighted Imaging With Contrast Enhancement in Detection of Multiple Sclerosis Active Plaques Using 1.5 Tesla Magnetic Resonance Imaging System Publisher



Afkandeh R1 ; Abedi I1 ; Shani A1 ; Rabbani M2 ; Shamsian S2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Medical Physics, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Department of Radiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Journal of Isfahan Medical School Published:2017


Abstract

Background: Magnetic resonance imaging with contrast enhancement (CE) is an essential method in the detection of active multiple sclerosis (MS) plaques. Nevertheless, in patients who are contraindicated with gadolinium, this method is not possible, and needs to be replaced. Susceptibility-weighted imaging (SWI) has been reported to be effective in detecting MS plaques, but its ability to detect active plaques is unclear. Methods: This cross-sectional study was performed on 147 patients with MS in Shafa Imaging Center, Isfahan, Iran, using 1.5 Tesla magnetic resonance imaging (MRI) System. In addition to conventional MRI sequences including T1, T2, FLAIR and CE-T1W, SWI sequences were also obtained. Then, the images of contrast enhancement, final SWI, and magnitude were examined and signal intensity was measured by drawing return on investment (ROI) in three areas of active plaque, passive plaque, and background. Findings: From 147 patients, 32 had active plaque. There was a direct and significant relationship between final SWI with CE as well as between magnitude and CE (P < 0.001). The final SWI had a sensitivity of 71.87 and a specificity of 91.30; and a magnitude of SWI had a sensitivity of 75 and a specificity of 87.83 in detecting active plaques. Moreover, the accuracy of determination of active plaques was 87.07% for final SWI and 85.03% for large-size ones. Conclusion: The results of our study show that SWI method is capable of detecting MS plaques with high sensitivity, specificity, and accuracy, and distinguishes active plaques from passive plaques as well. © 2017 Isfahan University of Medical Sciences(IUMS). All rights reserved.
Related Docs
View other Related Docs
1. Optimal B-Value in Diffusion Weighted Imaging for Detection Active Multiple Sclerosis Plaque, Using Contrast Enhancement Imaging, Journal of Isfahan Medical School (2021)
2. Comparison of Susceptibility Weighted Imaging With Conventional Mri Sequences in Multiple Sclerosis Plaque Assessment: A Cross-Sectional Study, Journal of Research in Medical Sciences (2021)
3. Detection of Multiple Sclerosis Lesions by Susceptibility-Weighted Imaging—A Systematic Review and Meta-Analyses, Clinical Radiology (2024)
4. Joint Application of Magnetic Resonance Imaging and Biochemical Biomarkers in Diagnosis of Multiple Sclerosis, Current Medicinal Chemistry (2020)
5. Conversion From Radiologically Isolated Syndrome to Multiple Sclerosis, International Journal of Preventive Medicine (2014)
6. Automatic Detection of Active and Inactive Multiple Sclerosis Plaques Using the Bayesian Approach in Susceptibility-Weighted Imaging, Acta Radiologica (2023)
7. Deep Learning for Discrimination of Active and Inactive Lesions in Multiple Sclerosis Using Non-Contrast Flair Mri: A Multicenter Study, Multiple Sclerosis and Related Disorders (2024)
8. Number and Volume of Demyelinative Plaques Can Predict the Response to Treatment in Patients With Multiple Sclerosis, Journal of Isfahan Medical School (2011)
Experts (# of related papers)
View all Related Experts
Masoud Etemadifar (25)
Vahid Shaygannejad (18)
Other Related Docs
9. Mri Features and Disability in Multiple Sclerosis: A Systematic Review and Meta-Analysis, Journal of Neuroradiology (2024)
10. Promising Effect of Rapamycin on Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2018)
11. Thalamic Asymmetry in Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2023)
12. Prognostic Value of Intrathecal Igg Synthesis in Multiple Sclerosis: A Study in 54 Patients, Tehran University Medical Journal (2008)
13. Concurrent Glioma and Multiple Sclerosis: A Systematic Review of Case Reports, Multiple Sclerosis and Related Disorders (2024)
14. Prescription Trends of Disease-Modifying Treatments for Multiple Sclerosis in Iran Over the Past 30 Years, Multiple Sclerosis and Related Disorders (2022)
15. T1 and T2 Weighted Lesions and Cognition in Multiple Sclerosis: A Systematic Review and Meta-Analysis, Journal of Clinical Neuroscience (2024)
16. Seizure in Iranian Patients With Multiple Sclerosis, Journal of Research in Medical Sciences (2013)
17. Prevalence of Familial Multiple Sclerosis in Isfahan, Iran, Journal of Isfahan Medical School (2011)
18. Effect of Deep Gray Matter Atrophy on Information Processing Speed in Early Relapsing-Remitting Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2023)
19. Multiple Sclerosis: Pathophysiology, Clinical Features, Diagnosis, and Management, Neuroinflammation (2011)
20. Evaluation of the Expressed Mir‑129 and Mir‑549A in Patients With Multiple Sclerosis, Advanced Biomedical Research (2021)
21. Late-Onset Multiple Sclerosis in Iran: A Report on Demographic and Disease Characteristics, Multiple Sclerosis and Related Disorders (2023)
22. Cognitive Function and Brain Magnetic Resonance Imaging Profiles in Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis, Journal of Research in Medical Sciences (2024)
23. Higher Latitude Is Significantly Associated With an Earlier Age of Disease Onset in Multiple Sclerosis, Journal of Neurology, Neurosurgery and Psychiatry (2016)
24. Pure Spinal Multiple Sclerosis: A Case Series of a Possible New Entity, Journal of Neuroimmunology (2025)
25. Neutralizing Antibodies in Multiple Sclerosis Patients on Weekly Intramuscular Avonex and Biosimilar Interferon Beta-1A (Cinnovex): Comparing Results of Measurements in Two Different Laboratories, Journal of Immunological Methods (2013)
26. Time Interval Between the Onset of Symptoms and Diagnosis of Multiple Sclerosis and the Influential Factors: A National Registry-Based Study, Clinical Neurology and Neurosurgery (2024)
27. Clinical and Epidemiological Aspects of Multiple Sclerosis in Children, Iranian Journal of Child Neurology (2017)
28. First-Year Treatment Response Predicts the Following 5-Year Disease Course in Patients With Relapsing-Remitting Multiple Sclerosis, Neurotherapeutics (2025)
29. Serum Homocysteine Level in Patients With Multiple Sclerosis, Journal of Research in Medical Sciences (2005)
30. Does Early-Onset Multiple Sclerosis Differ From Adult-Onset Form in Iranian People, Journal of Research in Medical Sciences (2010)
31. Serum Lipids and Cognitive Outcomes in Multiple Sclerosis; a Systematic Review and Meta-Analysis, Multiple Sclerosis and Related Disorders (2024)
32. Epidemiology of Familial Multiple Sclerosis in Iran: A National Registry-Based Study, BMC Neurology (2022)
33. Identification of Potential Biomarkers in the Peripheral Blood Mononuclear Cells of Relapsing–Remitting Multiple Sclerosis Patients, Inflammation (2022)
34. Multiple Sclerosis: Clinical Features, Pathophysiology, Neuroimaging and Future Therapies, Future Neurology (2009)
35. Association of Urodynamic Findings in New Onset Multiple Sclerosis With Subsequent Occurrence of Urinary Symptoms and Acute Episode of Disease in Females, Journal of Research in Medical Sciences (2012)
36. A Novel Approach to Discriminate Subgroups in Multiple Sclerosis, Iranian Journal of Allergy, Asthma and Immunology (2016)
37. Mri Signs of Cns Demyelinating Diseases, Multiple Sclerosis and Related Disorders (2021)
38. Prevalence of Multiple Sclerosis in Isfahan, Iran, Neuroepidemiology (2006)
39. Multiple Sclerosis in Isfahan, Iran, International Review of Neurobiology (2007)
40. Phase Sensitive Reconstruction of T1-Weighted Inversion Recovery in the Evaluation of the Cervical Cord Lesions in Multiple Sclerosis; Is It Similarly Eligible in 1.5 T Magnet Fields?, Multiple Sclerosis and Related Disorders (2018)
41. Childhood-Onset Multiple Sclerosis: Report of 82 Patients From Isfahan, Iran, Archives of Iranian Medicine (2007)
42. Safety and Efficacy of Mitoxantrone in Pediatric Patients With Aggressive Multiple Sclerosis, European Journal of Paediatric Neurology (2014)
43. Combination Therapy With Mitoxantrone and Plasma Exchange in Aggressive Relapsing Remitting Multiple Sclerosis: A Preliminary Clinical Study, Journal of Research in Medical Sciences (2012)
44. Early-Onset Multiple Sclerosis in Isfahan, Iran: Report of the Demographic and Clinical Features of 221 Patients, Journal of Child Neurology (2016)
45. Investigating the Feasibility of Differentiating Ms Active Lesions From Inactive Ones Using Texture Analysis and Machine Learning Methods in Dwi Images, Multiple Sclerosis and Related Disorders (2024)
46. Evaluation of the Relationship Between Axon Injury and Clinical Symptoms in Patients With Multiple Sclerosis Using Diffusion Tensor Mri Imaging; [بررسی ارتباط آسیب آکسون با علایم بالینی در بیماران مبتلا به مالتیپل اسکلروزیس Mri با استفاده از تصویربرداري انتشار تانسوري], Tehran University Medical Journal (2022)
47. Deep Learning and Classic Machine Learning Models in the Automatic Diagnosis of Multiple Sclerosis Using Retinal Vessels, Multimedia Tools and Applications (2024)
48. Clinical Characteristics and Disability Progression of Early-And Late-Onset Multiple Sclerosis Compared to Adult-Onset Multiple Sclerosis, Journal of Clinical Medicine (2020)
49. Headache in Radiologically Isolated Syndrome: A Hint Toward Imminent Conversion: A Case Report, Journal of Medical Case Reports (2025)
50. Multiparametric Study for Glioma Grading With Flair, Adc Map, Eadc Map, T1 Map, and Swi Images, Magnetic Resonance Imaging (2023)